Optimal management of drug-resistant tuberculosis: Can India lead the way?

Indian J Med Res. 2023 Feb-Mar;157(2&3):220-222. doi: 10.4103/ijmr.ijmr_300_23.

¹ Independent Consultant, Lucca, Italy.
² Department of Global Health & Social Medicine, Harvard Medical School, Boston, MA, USA.
³ Department of Chest Medicine, Hinduja Hospital & Research Center, Mumbai, India.
⁴ Center for Immunology and Infectious Diseases, Sorbonne University, INSERM, U1135; Bacteriology-Hygiene Laboratory, Pitie-Salpetriere Hospital, AP-HP Sorbonne University, National Reference Center for Mycobacteria and Resistance of Mycobacteria to Antituberculosis Drugs, Paris, France.

No abstract available

MeSH terms